Surprisingly, recombinant targeted Bacillus subtilis vaccine expressing PRV gC and gD proteins can effectively induce a mucosal immune response against this disease in recent study [189], and efficient protection provided by a gD-based subunit vaccine against PRV variant infection in pig models was also confirmed [190]. This evidence concerns the gene PAEP and acquired polycythemia vera.